considered a turning point in the diagnostic evaluation of Legionella pneumonia. The rate of diagnosis of Legionella pneumonia by urine antigen testing has increased from 0% to 69% in the United States, constitutes 73% of diagnostic procedures for Legionella pneumonia in Europe, and has resulted in a substantial increase in the diagnosis of Legionella pneumophila serogroup 1 infections [4, 5] . Moreover, the general view of the clinical presentation and outcome of Legionella pneumonia has experienced some important modification due to the availability of urine antigen testing [5] . Considerable debate continues concerning the optimal diagnostic and empirical treatment approach for Legionella pneumonia.
The establishment of the Competence Network for Community Acquired Pneumonia (CAPNETZ; http://www.cap netz.de) has been described in detail elsewhere [6] . Its main goals are to generate epidemiological data about CAP in Germany and to study and improve diagnostic procedures and care of both ambulatory and hospitalized patients. The network offers a unique opportunity to study the epidemiology of legionellosis throughout Germany, applying sophisticated diagnostic tools. Therefore, we analyzed the incidence, clinical characteristics, initial antimicrobial treatment, and outcome of community-acquired Legionella pneumonia in Germany.
MATERIALS AND METHODS

Patient population.
The inclusion criteria for the CAPNETZ study were age у18 years, the presence of a new infiltrat on chest radiography, and at least 1 of the following criteria: history of fever (temperature, у38.3ЊC), cough, production of purulent sputum, or focal chest signs on auscultation. Patients who had been hospitalized during the 28 days preceding the study because of severe immunosuppression or active tuberculosis were excluded. The study was approved by the ethical review board of each participating clinical center, and all patients included gave informed consent.
Data collection. In this prospective study, all demographic, clinical, and diagnostic data for the patients were recorded using standardized Web-based data sheets. Information on abdominal symptoms and travel history was not collected. The study period comprised 35 months from June 2002 through April 2005, thus including 3 autumn-winter seasons. All surviving patients had a follow-up visit 6 months after hospital discharge.
Microbiological processing and examination. Specimens of sputum and/or other respiratory secretions, urine, and serum were collected and sent to the CAPNETZ Central Study Unit (Ulm, Germany). In addition, all respiratory materials were immediately processed in the participating local microbiological laboratories. All respiratory pathogens isolated locally were sent to the Central Study Unit. After arrival at the core facility, the number and types of specimens were checked for completeness, and specimens were stored at Ϫ80ЊC.
Microbiological investigations and pathogen definition were applied according to German Quality Standards in Clinical Microbiology and Infectious Diseases [7] . Analysis of the specimens (confi mation of the species identification drug susceptibility testing, and DNA extraction) was performed en bloc. The DNA from the clinical samples was extracted using the QIAamp DNA Mini Kit (Qiagen) in accordance with the manufacturer's instructions [8] . Urine specimens were tested for the presence of Streptococcus pneumoniae and Legionella species antigens.
Isolated bacterial species were classifie as respiratory pathogens if the species (1) was detected in a valid respiratory sample (у25 neutrophils and !10 epithelial cells per highpower field magnification ϫ100), (2) represented the predominant growth in a respiratory sample culture, and (3) was recognized as a typical respiratory pathogen. The results of virus testing were not included in this report.
Investigation for Legionella species and criteria for Legionella pneumonia. Respiratory samples were cultured on selective, buffered, charcoal-yeast extract agar or a selective agar containing cefamandol, polymyxin B, and anisomycin without acid or heat treatment. Suspected pathogen colonies were identifie by standard serological techniques [9] . Isolated strains were serotyped by using a panel of monoclonal antibodies described elsewhere [10] .
Legionella DNA was sought in respiratory samples by PCR. All PCR examinations were performed at the German Reference Laboratory for Legionella Species at Dresden University (Dresden, Germany). The genus-specifi PCR assay amplifying a portion of the 16S rRNA gene was performed as described [11] . By using serial dilutions of Legionella bacteria as well as dilutions of the extracted DNA, the detection limit was determined to be 5-10 bacteria, corresponding to 5-10 fg of Legionella DNA per sample. To determine the disease-causing Legionella species, PCR products were purifie with the QIAquick PCR Purificatio Kit (Qiagen) according to the manufacturer's instructions. Sequencing was performed using BigDye Terminator version 1.1 with the ABI Prism 377 Sequencer (Applied Biosystems). Sequence analysis was performed by a BLAST search of the GenBank database [12] .
For the qualitative detection of L. pneumophila soluble antigen in urine, specimens were tested by a microtiter ELISA (Biotest Legionella Urine Antigen EIA; Mikrogen) according to the manufacturer's recommendations. Urine samples were not routinely concentrated before antigen analysis. However, if the test produced enhanced optical density values (i.e., less than the threshold but 10.1, which represents the optical density for the majority of samples) the urine was concentrated 10-fold using microcolumns. The urinary antigen test most effectively detected L. pneumophila serogroup 1. Other serotypes might also have been detected if a huge amount of antigen was present, because of possible cross-reactions between serogroups [13] .The test was performed in the German Reference Laboratory for Legionella Species at Dresden University.
The diagnosis of Legionella pneumonia was considered definite if the patient met у1 of the following criteria: (1) isolation of Legionella species from the culture of a respiratory sample; (2) detection by PCR; or (3) detection by urinary antigen testing.
Statistical analysis. Comparisons between groups were performed by means of the x 2 test for categorical variables or analysis of variance for continuous variables. All analyses were performed with SPSS software, version 10.0 (SPSS). All tests of significanc were 2-tailed, and a was set at 0.05.
RESULTS
General characteristics of study population. Overall, 2503 patients with CAP from 10 clinical centers throughout Germany were included in our analysis. The 1413 male and 1090 female patients had a mean age ‫ע(‬ SD) of years. A total of 61 ‫ע‬ 18 1727 patients (69%) were hospitalized at the time when they were firs contacted for participation in CAPNETZ. Fourteen hundred seventy patients (59%) had at least 1 comorbidity; chronic obstructive pulmonary disease was most frequent (35% of patients). Fifty-three percent of all patients presented with fever, 74% had dyspnea, and 9% were confused. Seventy-nine patients (3.2%) required mechanical ventilation, and 269 patients (10.7%) died. The demographic characteristics and clinical data of the patients are given in table 1.
Diagnosis and epidemiology of Legionella pneumonia. Respiratory samples were available for 876 (35%) of the patients. A definit pathogen from the respiratory samples was identifie in 581 (66%) of these patients. S. pneumoniae was isolated in 263 cases. By applying all diagnostic procedures, a definit pathogen was identifie in 971 patients (38.8%). Legionella species was diagnosed as the causative pathogen of pneumonia in 94 patients who had at least 1 clinical specimen available for testing; thus, some patients for whom sufficien clinical samples had been unobtainable may have been missed. The diagnosis was made in 29 outpatients (3.7%) and 65 hospitalized patients (3.8%). Diagnosis of Legionella pneumonia was based on a positive culture result for L. pneumophila in 3 patients (L. pneumophila serogroup 1, 2; L. pneumophila serogroup 3, 1), a positive PCR result from respiratory samples in 52 patients, and/or a positive urinary antigen test result in 48 patients (table 2) . On the basis of serotype results and sequencing of the PCR amplicons, the predominant Legionella species was L. pneumophila. Six cases were caused by other Legionella species (Legionella anisa, 2; Legionella bozemanii, 2; Legionella longbeachae, 1; Legionella erythra, 1). Because of poor quality sequencing results, a definit species identificatio was not achieved in 4 cases.
All cases of Legionella pneumonia were sporadic and not part of a cluster or outbreak. No seasonal or geographic variation in the incidence of Legionella pneumonia was observed during the study period. The regional distribution of Legionella pneumonia was comparable in all local clinical centers throughout Germany.
Clinical characteristics of patients with Legionella pneumonia. Patients with Legionella pneumonia were predominantly older men, were more likely to have diabetes, were heavier smokers, and more likely expectorated sputum. A purulent sputum sample was available from 29% of the patients. Patients with Legionella pneumonia received more antimicrobial agents active against atypical bacteria and had a higher fatality rate (12.8%; table 1).
When patients with a positive PCR result from respiratory samples were compared with patients with a positive urinary antigen test result, more patients with a positive urinary antigen test result were hospitalized at their firs presentation, and more patients died (table 3) . Significan differences were apparent between ambulatory and hospitalized patients with Legionella pneumonia. Outpatients (ambulatory patients) were signifi cantly younger, had fewer comorbidities, and experienced a less severe clinical course, and none died (table 4) .
Antimicrobial treatment and outcome of patients with Legionella pneumonia. Detailed data concerning antimicrobial treatment were available for 97% of patients; 1685 patients had received 1 antimicrobial agent, 719 patients had received a combination of 2 agents, and 22 patients had received a combination of 3 agents. For 4 patients, no antibiotic therapy was administered. All of these patients had low CRB-65 scores of 0 or 1, only 1 patient was hospitalized (no pathogen was identified) and all patients survived. The predominant classes of antimicrobial agents administered were macrolides or ketolides (38% of patients) and aminopenicillins plus b-lactamase inhibitors (28% of patients). Overall, 70% of patients with Legionella pneumonia had received antimicrobial agents active against atypical bacteria, whereas 30% received discordant treatment without excess mortality. The rate of discordant treatment was higher for hospitalized patients than outpatients (32% vs. 24%). Conversely, 58% of patients in whom Legionella pneumonia was not diagnosed had received an antibiotic treatment active against atypical bacterial.
In-hospital mortality within 30 days was 10.6% ( ), n p 10 including 4 early deaths within 4 days of hospitalization. Two additional patients with Legionella pneumonia died within 6 months after hospitalization (overall mortality, 12.8%).
Nine of 12 patients who died were men, and all had been hospitalized. Patients with fatal outcome were ∼10 years older than the mean age of the study population, and at least 6 of them had been heavy smokers (120 pack-years). Four patients who died had received discordant initial antimicrobial treat- 
DISCUSSION
The main finding of our study are the following: (1) Legionella species was one of the most frequent pathogens causing CAP in Germany and was equally frequent in ambulatory and hospitalized patients; (2) non-L. pneumophila species were present in ∼10% of cases of Legionella pneumonia, as detected by PCR testing of respiratory samples; (3) the urinary antigen test tended to yield positive results more frequently in patients with more severe pneumonia; (4) legionellosis in outpatients differed significantl from hospitalized patients in terms of clinical presentation and outcome; and (5) there was a high rate of discordant initial antimicrobial treatment (30%), with a higher rate in hospitalized patients. On the basis of our data, which reflec the analysis of large populations in different regions throughout Germany, it can be estimated that at least 15,000-30,000 cases of sporadic Legionella pneumonia occur per year in Germany. Additional cases may have been missed in our series because of the limited number of respiratory samples available. No bias occurred due to epidemics. The incidence observed is comparable to that presented in other reports, in particular reports from Spain. Thus, sporadic legionellosis should no longer be addressed primarily as a "Mediterranean disease" [4, 14] but must be equally taken into account in Germany and probably in most other western countries.
Legionella pneumonia was found to occur at identical frequencies in outpatients and inpatients (3.7% vs. 3.8% of cases). This is in clear contrast to previous data suggesting that Legionella is more often identifie as the causative organism for CAP in hospitalized patients [14] . This difference might be explained by the fact that CAPNETZ provided identical diagnostic options for all patients, whereas in other settings ambulatory patients might have been undergone a considerably minimized microbial investigation [15] .
Our findin that Legionella is equally found in ambulatory and hospitalized patients is important, because it challenges the current view that Legionella tends to be associated with more severe pneumonia and thus represents a pathogen with higher intrinsic pathogenicity. Instead, it seems that the severity of Legionella pneumonia mainly results from host-pathogen interactions, as is the case with most other respiratory pathogens.
Typing of isolated strains confi med that the majority of human infection is caused by L. pneumophila and predominantly by serogroup 1. Nevertheless, we found that ∼10% of infections were caused by Legionella species other than L. pneumophila. This might have important implications for the choice of diagnostic tests. Because only PCR and culture of respiratory samples are able to detect non-L. pneumophila infections, the widespread application of the urinary antigen test may lead to an underrecognition of other Legionella species.
In our study, patients with a positive urinary antigen test tended to experience a more severe clinical course. This findin is consistent with previous reports suggesting that the result of the urinary antigen test correlates with the severity of illness [16] [17] [18] and the presence of underlying diseases [19] . The association of antigen detection and severity of illness seems to be plausible given that the "antigen load" is higher in severe cases and the processing of the antigen might depend on the immune status of the host.
An intriguing findin of our study was the substantial differences between outpatients with Legionella pneumonia and hospitalized patients. In most other studies, patients with sporadic Legionella pneumonia were characterized as men of advanced age [20] [21] [22] , and several underlying diseases and conditions have been consistently implicated as risk factors for sporadic Legionella pneumonia [1, 9, 23] . This description holds true for hospitalized patients with Legionella pneumonia in our study; hospitalized patients experienced a more severe clinical course, more often had diabetes (35%) and severe hyponatremia (23%), and had a high mortality rate (18.5%). In contrast, outpatients were significantl younger, showed an equal sex distribution, had significantl fewer comorbidities, and invariably experienced an uncomplicated clinical course without fatalities. Overall, the rate of mortality due to Legionella pneumonia is still high, although it has decreased substantially since 1990, from 26% to 10% in community-acquired cases [5] . This estimate is close to the overall in-hospital mortality rate of 10.6%, and deaths at 6 months of follow-up of 12.8% in our study. However, it has to be recognized that legionellosis is equally distributed over the whole spectrum of disease severity, from a mild, essentially self-limiting disease to a severe life-threatening condition. This having been said, it should be stressed that appropriate coverage remains mandatory for any patient with Legionella pneumonia, including apparently mild disease. This is illustrated by the observation that 2 of 12 patients with fatal outcome in our series, who received discordant antimicrobial treatment, had presented with mild pneumonia as reflecte by a low CRB-65 score but worsened within hours. In addition to appropriate empirical initial coverage, the rapid initiation of adequate treatment for Legionella pneumonia may prevent fatal outcomes [24] [25] [26] .
The overall high rate of discordant antimicrobial treatment (30%) raises the question of how to increase the rate of adequate treatment. In our study, the overall yield of testing for Legionella species appeared to be quite low. The recently updated Infectious Diseases Society of America (Arlington, VA) guidelines have recommended testing for Legionella species only in patients with "enigmatic" pneumonia, in patients who do not respond to b-lactam treatment, and in the presence of an epidemic; the guidelines advocated the use of broad-spectrum treatment covering pneumococci as well as Legionella species in all patients with severe CAP [27] . This approach has been subject to criticism [28] . In fact, the definitio of "enigmatic" pneumonia remains unclear, and several approaches to predict a higher probability of the presence of legionellosis have failed to achieve acceptable accuracy [19, 20] . This was also confi med in our series. Moreover, restricting testing to patients for whom b-lactam treatment failed may impose a considerable risk for excess mortality. Therefore, it seems reasonable to consider testing all patients with CAP who are at increased risk of death, which means all patients hospitalized for reasons of pneumonia severity. Alternatively, having in mind the improbability of dual infection with pneumococci and Legionella species, urinary antigen testing for Legionella might be restricted to patients with negative test results for pneumococci.
In conclusion, sporadic Legionella is an important pathogen equally frequent among ambulatory and hospitalized patients with CAP. The reliance on urine antigen test results in a small but potentially relevant underrecognition of non-L. pneumophila species and of mild Legionella pneumonia. Legionella pneumonia in ambulatory patients differs strikingly from that in hospitalized patients in terms of clinical characteristics and outcome. High rates of initial discordant antimicrobial treatment may be overcome by regular urine antigen testing for L. pneumophila (perhaps in the case of negative test results for pneumococci) in all hospitalized patients.
